Medicine:Reversible cerebral vasoconstriction syndrome
| Reversible cerebral vasoconstriction syndrome |
|---|
Reversible cerebral vasoconstriction syndrome (RCVS, sometimes called Call-Fleming syndrome) is a disease characterized by a weeks-long course of thunderclap headaches, sometimes focal neurologic signs, and occasionally seizures.[1] Symptoms are thought to arise from transient abnormalities in the blood vessels of the brain.[1] In some cases, it may be associated with childbirth, vasoactive or illicit drug use, or complications of pregnancy.[1] If it occurs after delivery it may be referred to as postpartum cerebral angiopathy.
For the vast majority of patients, all symptoms disappear on their own within three weeks.[1] Deficits persist in a small minority of patients, with severe complications or death being very rare.[1] Because symptoms resemble a variety of life-threatening conditions, differential diagnosis is necessary.[1]
Signs and symptoms
The key symptom of RCVS is recurrent thunderclap headaches, which over 95% of patients experience.[1] In two-thirds of cases, it is the only symptom.[1] These headaches are typically bilateral, very severe and peak in intensity within a minute.[1] They may last from minutes to days, and may be accompanied by nausea, photophobia, phonophobia or vomiting.[1] Some patients experience only one headache, but on average there are four attacks over a period of one to four weeks.[1] A milder, residual headache persists between severe attacks for half of patients.[1]
1–17% of patients experience seizures. 8–43% of patients show neurologic problems, especially visual disturbances, but also hemiplegia, ataxia, dysarthria, aphasia, and numbness.[1] These neurologic issues typically disappear within minutes or a few hours; more persistent symptoms may indicate a stroke.[1] Posterior reversible encephalopathy syndrome is present in a small minority of patients.[2][3][4]
This condition features the unique property that the patient's cerebral arteries can spontaneously constrict and relax back and forth over a period of time without intervention and without clinical findings. Vasospasm is common post subarachnoid hemorrhage and cerebral aneurysm, but in RCVS only 25% of patients have symptoms post subarachnoid hemorrhage.[5]
Causes
The direct cause of the symptoms is believed to be either constriction or dilation of blood vessels in the brain.[1] The pathogenesis is not known definitively, and the condition is likely to result from multiple different disease processes.[6]
Up to two-thirds of RCVS cases are associated with an underlying condition or exposure, particularly vasoactive or recreational drug use, complications of pregnancy (eclampsia and pre-eclampsia), and the adjustment period following childbirth called puerperium.[1] Vasoactive drug use is found in about 50% of cases.[6] Implicated drugs include selective serotonin reuptake inhibitors, weight-loss pills such as Hydroxycut, alpha-sympathomimetic decongestants, acute migraine medications, pseudoephedrine, epinephrine, cocaine, and cannabis, among many others.[1] It sometimes follows blood transfusions, certain surgical procedures, swimming, bathing, high altitude experiences, sexual activity, exercise, or coughing.[1] Symptoms can take days or a few months to manifest after a trigger.[6]
Following a study and publication in 2007, it is also thought SSRIs, uncontrolled hypertension, endocrine abnormality, and neurosurgical trauma are indicated to potentially cause vasospasm.[7]
Diagnosis
The clinician should first rule out conditions with similar symptoms, such as subarachnoid hemorrhage, ischemic stroke, pituitary apoplexy, cerebral artery dissection, meningitis, and spontaneous cerebrospinal fluid leak.[1] This may involve a CT scan, lumbar puncture, MRI, and other tests.[1] Posterior reversible encephalopathy syndrome has a similar presentation, and is found in 10–38% of RCVS patients.[1]
RCVS is diagnosed by detecting diffuse reversible cerebral vasoconstriction.[1] Catheter angiography is ideal, but computed tomography angiography and magnetic resonance angiography can identify about 70% of cases.[1] Multiple angiographies may be necessary.[1] Because other diseases (such as atherosclerosis) have similar angiographic presentations, it can only be conclusively diagnosed if vasoconstriction resolves within 12 weeks.[1]
Treatment
As of 2014, no treatment strategy has yet been investigated in a randomized clinical trial.[1] Verapamil, nimodipine, and other calcium channel blockers may help reduce the intensity and frequency of the headaches.[1] A clinician may recommend rest and the avoidance of activities or vasoactive drugs which trigger symptoms (see § Causes).[1] Analgesics and anticonvulsants can help manage pain and seizures, respectively.[1]
Prognosis
All symptoms normally resolve within three weeks, and may only last days.[1] Permanent deficits are seen in a minority of patients, ranging from under 10% to 20% in various studies.[1] Less than 5% of patients experience progressive vasoconstriction, which can lead to stroke, progressive cerebral edema, or even death.[1] Severe complications appear to be more common in postpartum mothers.[6]
Epidemiology
The incidence of RCVS is unknown, but it is believed to be "not uncommon", and likely under-diagnosed.[1][6] One small, possibly biased study found that the condition was eventually diagnosed in 45% of outpatients with sudden headache, and 46% of outpatients with thunderclap headache.[1]
The average age of onset is 42, but RCVS has been observed in patients aged from 19 months to 70 years.[1] Children are rarely affected.[1] It is more common in females, with a female-to-male ratio of 2.4:1.[6]
History
Case studies of the condition first appeared in the 1960s, but it was not then recognized as a distinct entity.[6] In 1983, French researchers published a case series of 11 patients, terming the condition acute benign cerebral angiopathy.[1] Gregory Call and Marie Fleming were the first two authors of a report in which doctors from Massachusetts General Hospital, led by C. Miller Fisher, described 4 patients, alongside 12 previous case studies, with the characteristic symptoms and abnormal cerebral angiogram findings.[6][8] The name Call-Fleming syndrome refers to these researchers.[1]
A 2007 review by Leonard Calabrese and colleagues proposed the name reversible cerebral vasoconstriction syndrome, which has since gained widespread acceptance.[1][9] This name merges various conditions that were previously treated as distinct entities, including Call-Fleming syndrome, postpartum angiopathy, and drug-induced angiopathy.[6] Other names may still be used for particular forms of the condition.[1]
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 1.22 1.23 1.24 1.25 1.26 1.27 1.28 1.29 1.30 1.31 1.32 1.33 1.34 1.35 1.36 1.37 1.38 1.39 Mehdi, A.; Hajj-Ali, R. A. (2014). "Reversible cerebral vasoconstriction syndrome: a comprehensive update". Current Pain and Headache Reports 18 (9): 1–10. doi:10.1007/s11916-014-0443-2. PMID 25138149.
- ↑ Chen, Shih-Pin; Fuh, Jong-Ling; Wang, Shuu-Jiun (2010). "Reversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency". Ther Adv Neurol Disord. 3 (3): 161–171. doi:10.1177/1756285610361795. PMID 21179608.
- ↑ "Reversible Cerebral Vasoconstriction Syndrome, Part 1 Epidemiology, Pathogenesis, and Clinical Course". American Journal of Neuroradiology 36 (8): 1392–9. 2015. doi:10.3174/ajnr.A4214. PMID 25593203. PMC 7964694. http://www.annals.org/content/146/1/34.full.pdf.
- ↑ "Reversible cerebral vasoconstriction syndrome". The Lancet Neurology 11 (10): 906–17. 2012. doi:10.1016/s1474-4422(12)70135-7. PMID 22995694. http://www.thelancet.com/pdfs/journals/laneur/PIIS1474-4422(12)70135-7.pdf.
- ↑ "Call-Fleming syndrome associated with subarachnoid haemorrhage: three new cases". Journal of Neurology, Neurosurgery & Psychiatry 79 (5): 602–5. 2008. doi:10.1136/jnnp.2007.134635. PMID 18077478.
- ↑ 6.0 6.1 6.2 6.3 6.4 6.5 6.6 6.7 6.8 Miller, T. R.; Shivashankar, R.; Mossa-Basha, M.; Gandhi, D. (2015). "Reversible cerebral vasoconstriction syndrome, part 1: epidemiology, pathogenesis, and clinical course". American Journal of Neuroradiology 36 (8): 1392–1399. doi:10.3174/ajnr.A4214. PMID 25593203. PMC 7964694. http://www.ajnr.org/content/early/2015/01/15/ajnr.A4214.full.pdf.
- ↑ "Narrative review: reversible cerebral vasoconstriction syndromes". Ann. Intern. Med. 146 (1): 34–44. January 2007. doi:10.7326/0003-4819-146-1-200701020-00007. PMID 17200220.
- ↑ "Reversible cerebral segmental vasoconstriction". Stroke 19 (9): 1159–70. 1988. doi:10.1161/01.str.19.9.1159. PMID 3046073.
- ↑ "Narrative review: reversible cerebral vasoconstriction syndromes". Annals of Internal Medicine 146 (1): 34–44. 2007. doi:10.7326/0003-4819-146-1-200701020-00007. PMID 17200220.
External links
| Classification |
|---|
 |  |
